Patents by Inventor John M. Marlett

John M. Marlett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antitoxin and vaccine platform based on nodavirus VLPS
    Patent number: 8404247
    Abstract: Antitoxin and vaccine compositions based on nodavirus VLPs are provided. Anthrax antitoxin and vaccine compositions are provided. Methods of treating toxins with VLP-based antitoxins are provided. Methods of raising an immune response with immunogen decorated VLPs are provided.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: March 26, 2013
    Assignees: The Salk Institute for Biological Studies, The Scripps Research Institute
    Inventors: John Young, Anette Schneemann, Marianne Manchester, Kelly Dryden, John M. Marlett, Darly Joseph Manayani, Godfrey Jonah Anderson Rainey, Vijay Reddy, Marc E. Siladi, Heather M. Scobie, Diane Thomas, Mark Yeager
  • Novel Antitoxin and Vaccine Platform Based on Nodavirus VLPS
    Publication number: 20120156237
    Abstract: Antitoxin and vaccine compositions based on nodavirus VLPs are provided. Anthrax antitoxin and vaccine compositions are provided. Methods of treating toxins with VLP-based antitoxins are provided. Methods of raising an immune response with immunogen decorated VLPs are provided.
    Type: Application
    Filed: June 23, 2011
    Publication date: June 21, 2012
    Applicants: THE SCRIPPS RESEARCH INSTITUTE, THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
    Inventors: JOHN YOUNG, ANETTE SCHNEEMANN, MARIANNE MANCHESTER, KELLY DRYDEN, JOHN M. MARLETT, DARLY JOSEPH MANAYANI, GODFREY JONAH ANDERSON RAINEY, VIJAY REDDY, MARC E. SILADI, HEATHER M. SCOBIE, DIANE THOMAS, MARK YEAGER
  • Antitoxin and vaccine platform based on nodavirus VLPs
    Patent number: 7998487
    Abstract: Antitoxin and vaccine compositions based on nodavirus VLPs are provided. Anthrax antitoxin and vaccine compositions are provided. Methods of treating toxins with VLP-based antitoxins are provided. Methods of raising an immune response with immunogen decorated VLPs are provided.
    Type: Grant
    Filed: February 14, 2008
    Date of Patent: August 16, 2011
    Assignees: The Salk Institute for Biological Studies, The Scripps Research Institute
    Inventors: John Young, Anette Schneemann, Marianne Manchester, Kelly Dryden, John M. Marlett, Darly Joseph Manayani, Godfrey Jonah Anderson Rainey, Vijay Reddy, Marc E. Siladi, Heather M. Scobie, Diane Thomas, Mark Yeager
  • Novel antitoxin and vaccine platform based on nodavirus VLPS
    Publication number: 20080299148
    Abstract: Antitoxin and vaccine compositions based on nodavirus VLPs are provided. Anthrax antitoxin and vaccine compositions are provided. Methods of treating toxins with VLP-based antitoxins are provided. Methods of raising an immune response with immunogen decorated VLPs are provided.
    Type: Application
    Filed: February 14, 2008
    Publication date: December 4, 2008
    Applicants: The Salk Institute for Biological Studies, The Scripps Research Institute
    Inventors: John Young, Anette Schneemann, Marianne Manchester, Kelly Dryden, John M. Marlett, Darly Joseph Manayani, Godfrey Jonah Anderson Rainey, Vijay Reddy, Marc E. Siladi, Heather M. Scobie, Diane Thomas, Mark Yeager